Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.4.1.9
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Statements Of Operations [Abstract]    
Revenue      
Operating expenses:    
Research and development, net of reimbursements 4,048,714us-gaap_ResearchAndDevelopmentExpense 1,589,776us-gaap_ResearchAndDevelopmentExpense
General and administrative 3,806,405us-gaap_GeneralAndAdministrativeExpense 2,547,245us-gaap_GeneralAndAdministrativeExpense
Depreciation expense 10,395us-gaap_Depreciation 1,405us-gaap_Depreciation
Total operating expenses 7,865,514us-gaap_OperatingExpenses 4,138,426us-gaap_OperatingExpenses
Loss from operations (7,865,514)us-gaap_OperatingIncomeLoss (4,138,426)us-gaap_OperatingIncomeLoss
Other income (expense):    
Interest expense (5,727)us-gaap_InterestExpenseOther   
Gain (loss) on change in fair value of derivative liabilities 4,796,378us-gaap_DerivativeGainLossOnDerivativeNet (12,561,071)us-gaap_DerivativeGainLossOnDerivativeNet
Total other income (expense) 4,790,651us-gaap_NonoperatingIncomeExpense (12,561,071)us-gaap_NonoperatingIncomeExpense
Net loss $ (3,074,863)us-gaap_NetIncomeLoss $ (16,699,497)us-gaap_NetIncomeLoss
Net loss per common share - basic and diluted $ (0.09)us-gaap_EarningsPerShareBasicAndDiluted $ (0.66)us-gaap_EarningsPerShareBasicAndDiluted
Weighted average common shares outstanding - basic and diluted 33,256,352us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 25,228,299us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted